HEM Pharma Registered Executive Bak So-yeong Increases Stake by 0.12% via Stock Option Exercise

HEM Pharma registered executive Bak So-yeong exercised stock options on July 6, 2026, acquiring 9,960 common shares at an exercise price of 10,000 KRW per share.
Following the exercise, Bak's holdings increased from 43,200 to 53,160 shares, raising her ownership ratio from 0.62% to 0.74%.
The exercise price is significantly below the current market price of 39,900 KRW, generating substantial profit for the insider, but the dilution from new share issuance is minimal at less than 0.14%.
[AI Summary]This filing reports an insider's equity change due to stock option exercise; the dilution impact is negligible and unrelated to corporate capital allocation or dividend policy. It is a routine disclosure with no material effect on shareholder value.